Journal of Computer-Aided Molecular Design

, Volume 23, Issue 8, pp 453–458 | Cite as

Fragment-based drug discovery

Warr's Piece
First Online:
Received:
Accepted:

Keywords

Surface Plasmon Resonance High Throughput Screening Fluorescence Correlation Spectroscopy Fragment Library Ligand Efficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

I am grateful to Rod Hubbard of Vernalis and Mark Murko of Vertex for giving balanced answers to my many challenging questions and to David Bailey of IOTA Pharmaceuticals [22] for helping me with Table 1. I would also like to thank several people who have given me ideas but wished to remain anonymous.

References

  1. 1.
    Hilpert K, Ackermann J, Banner DW, Gast A, Gubernator K, Hadvary P, Labler L, Mueller K, Schmid G, Tschopp TB, van de Waterbeemd H (1994) J Med Chem 37:3889CrossRefGoogle Scholar
  2. 2.
    Shuker SB, Hajduk PJ, Meadows RP, Fesik SW (1996) Science 274:1531CrossRefGoogle Scholar
  3. 3.
    Allen KN, Bellamacina CR, Ding X, Jeffery CJ, Mattos C, Petsko GA, Ringe D (1996) J Phys Chem 100(7):2605CrossRefGoogle Scholar
  4. 4.
    Hann MM, Leach AR, Harper G (2001) J Chem Inf Comput Sci 41:856Google Scholar
  5. 5.
    Fragments 2009 conference organized by the Royal Society of Chemistry Biological and Medicinal Chemistry Group at AstraZeneca, Cheshire, England, March 4–5, 2009Google Scholar
  6. 6.
    Kuntz ID, Chen K, Sharp K, Kollman P (1999) PNAS 96:9997CrossRefGoogle Scholar
  7. 7.
    Hopkins AL, Groom CR, Alex A (2004) Drug Discovery Today 9:430CrossRefGoogle Scholar
  8. 8.
    Leeson PD, Springthorpe B (2007) Nat Rev Drug Discovery 6:881CrossRefGoogle Scholar
  9. 9.
    Congreve M, Chessari G, Tisi D, Woodhead AJ (2008) J Med Chem 51:3661CrossRefGoogle Scholar
  10. 10.
    Abad-Zapatero C, Metz JT (2005) Drug Discovery Today 10(7):464CrossRefGoogle Scholar
  11. 11.
    Congreve M, Carr R, Murray C, Jhoti H (2003) Drug Discovery Today 8(19):867CrossRefGoogle Scholar
  12. 12.
    Hubbard RE, Chen L, Davis B, Drysdale MJ (2007) Curr Top Med Chem 7:1568CrossRefGoogle Scholar
  13. 13.
    Everts S (2008) Chem Eng News 86(29):15Google Scholar
  14. 14.
    Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, Joseph MK, Kitada S, Korsmeyer SJ, Kunzer AR, Letai A, Li C, Mitten MJ, Nettesheim DG, Ng S, Nimmer PM, O’Connor JM, Oleksijew A, Petros AM, Reed JC, Shen W, Tahir SK, Thompson CB, Tomaselli KJ, Wang B, Wendt MD, Zhang H, Fesik SW, Rosenberg SH (2005) Nature 435(7042):677CrossRefGoogle Scholar
  15. 15.
    Petros AM, Dinges J, Augeri DJ, Baumeister SA, Betebenner DA, Bures MG, Elmore SW, Hajduk PJ, Joseph MK, Landis SK, Nettesheim DG, Rosenberg SH, Shen W, Thomas S, Wang X, Zanze I, Zhang H, Fesik SW (2006) J Med Chem 49:656CrossRefGoogle Scholar
  16. 16.
    Vanwetswinkel S, Heetebrij RJ, van Duynhoven J, Hollander JG, Fillipov DV, Hajduk PJ, Siegal G (2005) Chem Biol 12(2):207CrossRefGoogle Scholar
  17. 17.
    Hajduk PJ, Greer J (2007) Nat Rev Drug Discovery 6:211CrossRefGoogle Scholar
  18. 18.
    Carlson HA, Smith RD, Khazanov NA, Kirchhoff PD, Dunbar JB, Benson ML (2008) J Med Chem 51:6432CrossRefGoogle Scholar
  19. 19.
    Hubbard RE, Chen I, Davis B (2007) Curr Opin Drug Discovery Dev 10(3):289Google Scholar
  20. 20.
    de Kloe GE, Bailey D, Leurs R, de Esch IJP (2009) Drug Discovery Today doi: 10.1016/j.drudis.2009.03.009 (in press)
  21. 21.
    Baines W (2006) Drug Discovery World. Summer:28Google Scholar
  22. 22.
    The Drug Design Resource sponsored by IOTA Pharmaceuticals http://drugdesignresource.com/index.php. Accessed April 2009

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  1. 1.Wendy Warr & AssociatesCheshireUK

Personalised recommendations